Blueprint Genetics is a comprehensive genetic diagnostics service provider in the field of non-cancer hereditary disorders
2017
Year invested
Fund I
MTIP Fund
Helsinki, Finland
Location
Sold Investment
Investment status
Genetic Testing
Segment
Blueprint Genetics’ mission is to support healthcare professionals in finding the best care for patients and families with rare inherited diseases. The company does this by delivering answers based on fast, affordable, and comprehensive genetic diagnostics and enhanced artificial intelligence technology. It has combined advanced genetic testing with enhanced knowledge about the field to provide the most comprehensive and actionable diagnostic reports for practitioners in all medical specialties.
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.